Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
作者信息
Gupta Ravindra K
机构信息
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK.
出版信息
Nat Rev Immunol. 2021 Jun;21(6):405. doi: 10.1038/s41577-021-00560-9.
Abstract
摘要
相似文献
1
Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
Nat Rev Immunol. 2021 Jun;21(6):405. doi: 10.1038/s41577-021-00560-9.
2
SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.
Signal Transduct Target Ther. 2021 May 22;6(1):203. doi: 10.1038/s41392-021-00623-2.
3
Author Correction: Development of a model-inference system for estimating epidemiological characteristics of SARS-CoV-2 variants of concern.
Nat Commun. 2021 Dec 16;12(1):7360. doi: 10.1038/s41467-021-27703-9.
4
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
5
Author Correction: Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.
Commun Biol. 2021 Mar 3;4(1):311. doi: 10.1038/s42003-021-01867-y.
6
Author Correction: SARS-CoV-2 and HIV-1 - A Tale of Two Vaccines.
Nat Rev Immunol. 2022 Jan;22(1):66. doi: 10.1038/s41577-021-00671-3.
7
Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Immunobiology. 2020 May;225(3):151955. doi: 10.1016/j.imbio.2020.151955. Epub 2020 May 11.
8
Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents.
Biochem Biophys Res Commun. 2020 Aug 20;529(2):263-269. doi: 10.1016/j.bbrc.2020.05.179. Epub 2020 Jun 8.
9
Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.
Nat Commun. 2021 Apr 1;12(1):2144. doi: 10.1038/s41467-021-22614-1.
10
Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2.
Cell Res. 2022 Jun;32(6):600. doi: 10.1038/s41422-022-00654-6.
引用本文的文献
1
Discovery of Hybrid Thiouracil-Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus's Polymerase "RdRp" as a Confirmed Interacting Biomolecule.
ACS Omega. 2023 Jul 14;8(30):27056-27066. doi: 10.1021/acsomega.3c02079. eCollection 2023 Aug 1.
2
Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants.
Diabetes Metab Syndr. 2022 Apr;16(4):102482. doi: 10.1016/j.dsx.2022.102482. Epub 2022 Apr 8.
3
Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China.
Front Med (Lausanne). 2022 Jan 10;8:784632. doi: 10.3389/fmed.2021.784632. eCollection 2021.
4
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
5
SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
Gene Rep. 2021 Dec;25:101378. doi: 10.1016/j.genrep.2021.101378. Epub 2021 Oct 4.
Zotero 插件